Rv2638 Anti-sigma F factor antagonist (spoIIAA-2); Anti-sigma B factor antagonist RsbV
Rv2638 (Anti-sigma F factor antagonist (spoIIAA-2); Anti-sigma B factor antagonist RsbV) is predicted to be co-regulated in modules bicluster_0401 with residual 0.58 and bicluster_0545 with residual 0.66.
This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 100.00 and 180.00 for bicluster_0401 and 0.00 and 1.40 for bicluster_0545 respectively.
These modules are enriched for following go terms: monovalent inorganic cation transport, metal ion transport, cation-transporting ATPase activity, metal ion transmembrane transporter acti..., monovalent inorganic cation transmembran..., ATPase activity, coupled to transmembran....
This gene is found to be for growth on cholesterol.
|Product (LegacyBRC)||Product (RefSeq)|
|Putative uncharacterized protein|
|BioCyc Gene Page||Cellular Overview Map|
Quantitative Proteomics Data
TRIP log2 fold abundance change
reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.